Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Post by NorthBayStreeton Aug 16, 2020 7:59pm

233 Views

Post# 31415666

From Bullmarketrun

Jon, hearing Sona management is in blackout since Friday. Have you heard anything to this effect?

Comment by Dan1 — August 15, 2020 @ 8:46 pm
Can’t confirm that this morning but have heard the same rumor, Dan1…would not be surprising as the final information comes together (clinical trial results) for FDA submission…given the testing situation in U.S., the FDA will be under pressure to quickly approve SONA test…24 hours to 7 days is the best guess, from time of submission…

Comment by Jon - BMR — August 16, 2020 @ 6:46 am
Hi Dan And Jon , Ive heard the same rumour with Sona

Comment by Vancouverisland — August 16, 2020 @ 12:50 pm
There was approval of a test yesterday by the FDA, which is encouraging with regard to SONA as it completes its trials and submits to the FDA shortly.

The Food and Drug Administration issued an emergency use authorization (EUA) to Yale School of Public Health for its SalivaDirect COVID-19 diagnostic test, which uses a new method of processing saliva samples when testing for COVID-19 infection.